FI4009942T3 - Yhdistelmähoitoon tarkoitettu yhdiste - Google Patents
Yhdistelmähoitoon tarkoitettu yhdiste Download PDFInfo
- Publication number
- FI4009942T3 FI4009942T3 FIEP20751149.4T FI20751149T FI4009942T3 FI 4009942 T3 FI4009942 T3 FI 4009942T3 FI 20751149 T FI20751149 T FI 20751149T FI 4009942 T3 FI4009942 T3 FI 4009942T3
- Authority
- FI
- Finland
- Prior art keywords
- compound
- years old
- used according
- erectile dysfunction
- man
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims 18
- 208000010228 Erectile Dysfunction Diseases 0.000 claims 10
- 201000001881 impotence Diseases 0.000 claims 10
- 239000000935 antidepressant agent Substances 0.000 claims 4
- 229940005513 antidepressants Drugs 0.000 claims 4
- 241000124008 Mammalia Species 0.000 claims 3
- 230000001430 anti-depressive effect Effects 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 208000020401 Depressive disease Diseases 0.000 claims 1
- 230000002411 adverse Effects 0.000 claims 1
- 230000003556 anti-epileptic effect Effects 0.000 claims 1
- 229940125713 antianxiety drug Drugs 0.000 claims 1
- 239000001961 anticonvulsive agent Substances 0.000 claims 1
- 229960003965 antiepileptics Drugs 0.000 claims 1
- 239000002249 anxiolytic agent Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 claims 1
- 229960004039 finasteride Drugs 0.000 claims 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19190224 | 2019-08-06 | ||
| PCT/EP2020/072092 WO2021023805A1 (en) | 2019-08-06 | 2020-08-06 | Compound for combination treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI4009942T3 true FI4009942T3 (fi) | 2023-09-26 |
Family
ID=67551141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIEP20751149.4T FI4009942T3 (fi) | 2019-08-06 | 2020-08-06 | Yhdistelmähoitoon tarkoitettu yhdiste |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20220288052A1 (https=) |
| EP (2) | EP4009942B1 (https=) |
| JP (1) | JP7605825B2 (https=) |
| KR (1) | KR20220054593A (https=) |
| CN (1) | CN114430679A (https=) |
| AU (1) | AU2020326244B2 (https=) |
| BR (1) | BR112022002169A2 (https=) |
| CA (1) | CA3146837A1 (https=) |
| DK (1) | DK4009942T3 (https=) |
| ES (1) | ES2962648T3 (https=) |
| FI (1) | FI4009942T3 (https=) |
| IL (1) | IL290319B2 (https=) |
| MX (1) | MX2022000356A (https=) |
| PL (1) | PL4009942T3 (https=) |
| WO (1) | WO2021023805A1 (https=) |
| ZA (1) | ZA202200723B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4646204A1 (en) * | 2023-01-03 | 2025-11-12 | Initiator Pharma A/S | Compound for treatment of erectile dysfunction |
| WO2025051846A1 (en) | 2023-09-05 | 2025-03-13 | Initiator Pharma A/S | Compound for treatment of female sexual dysfunction |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA04012693A (es) * | 2002-06-20 | 2005-03-23 | Lundbeck & Co As H | Terapia de combinacion en donde se utiliza un inhibidor de recaptacion de serotonina. |
| RU2354377C2 (ru) * | 2003-07-11 | 2009-05-10 | Берингер Ингельхайм Ветмедика Гмбх | Способ лечения или предупреждения заболеваний центральной нервной системы с использованием соединений, обладающих селективностью в отношении альфа-3-субъединицы бензодиазепинового рецептора |
| BRPI0515261A (pt) * | 2004-09-30 | 2008-07-15 | Neurosearch As | composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso do composto quìmico ou de qualquer um de seus isÈmeros ou de qualquer mistura de seus isÈmeros, ou um sal farmaceuticamente aceitável do mesmo, e, método para o tratamento, a prevenção ou o alìvio de uma doença ou de um distúrbio ou de uma condição de um corpo de animal vivo |
| WO2008074798A1 (en) * | 2006-12-20 | 2008-06-26 | Neurosearch A/S | Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| BRPI0917802A2 (pt) * | 2008-08-21 | 2016-03-01 | Neurosearch As | método para tratar um distúrbio de ansiedade, composição farmacêutica, uso do composto, uso de uma combinação, kit de partes, método para tratar, prevenir ou aliviar um distúrbio de ansiedade de um corpo de animal vivo, e, combinação |
| US20130040985A1 (en) | 2010-01-29 | 2013-02-14 | Neurosearch A/S | Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
-
2020
- 2020-08-06 WO PCT/EP2020/072092 patent/WO2021023805A1/en not_active Ceased
- 2020-08-06 CA CA3146837A patent/CA3146837A1/en active Pending
- 2020-08-06 EP EP20751149.4A patent/EP4009942B1/en active Active
- 2020-08-06 US US17/632,323 patent/US20220288052A1/en active Pending
- 2020-08-06 KR KR1020227005609A patent/KR20220054593A/ko active Pending
- 2020-08-06 PL PL20751149.4T patent/PL4009942T3/pl unknown
- 2020-08-06 AU AU2020326244A patent/AU2020326244B2/en active Active
- 2020-08-06 CN CN202080056000.7A patent/CN114430679A/zh active Pending
- 2020-08-06 DK DK20751149.4T patent/DK4009942T3/da active
- 2020-08-06 JP JP2022506360A patent/JP7605825B2/ja active Active
- 2020-08-06 BR BR112022002169A patent/BR112022002169A2/pt unknown
- 2020-08-06 ES ES20751149T patent/ES2962648T3/es active Active
- 2020-08-06 EP EP23183643.8A patent/EP4241839A3/en active Pending
- 2020-08-06 MX MX2022000356A patent/MX2022000356A/es unknown
- 2020-08-06 FI FIEP20751149.4T patent/FI4009942T3/fi active
-
2022
- 2022-01-14 ZA ZA2022/00723A patent/ZA202200723B/en unknown
- 2022-02-03 IL IL290319A patent/IL290319B2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021023805A1 (en) | 2021-02-11 |
| MX2022000356A (es) | 2022-05-11 |
| CN114430679A (zh) | 2022-05-03 |
| ES2962648T3 (es) | 2024-03-20 |
| BR112022002169A2 (pt) | 2022-06-07 |
| AU2020326244B2 (en) | 2025-06-05 |
| AU2020326244A1 (en) | 2022-03-17 |
| IL290319A (en) | 2022-04-01 |
| IL290319B2 (en) | 2023-06-01 |
| DK4009942T3 (da) | 2023-10-23 |
| EP4009942B1 (en) | 2023-08-09 |
| EP4009942A1 (en) | 2022-06-15 |
| CA3146837A1 (en) | 2021-02-11 |
| ZA202200723B (en) | 2022-08-31 |
| EP4241839A2 (en) | 2023-09-13 |
| JP7605825B2 (ja) | 2024-12-24 |
| US20220288052A1 (en) | 2022-09-15 |
| JP2022544463A (ja) | 2022-10-19 |
| PL4009942T3 (pl) | 2024-04-08 |
| EP4241839A3 (en) | 2023-11-15 |
| KR20220054593A (ko) | 2022-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20220902T3 (hr) | Pripravci i njihova upotreba u liječenju multiple skleroze | |
| FI4310087T3 (fi) | Silloitettuja trisyklisiä karbamoyylipyridoniyhdisteitä ja niiden käyttötapoja | |
| JP2017506624A5 (https=) | ||
| FI3646876T3 (fi) | Telomeraasinestäjä imetelstaatti myeloproliferatiivisten sairauksien ja myeloproliferatiivisten kasvainten hoitoa varten | |
| MX2020014000A (es) | Formulaciones en lámina que contienen dexmedetomidina y métodos para producirlas. | |
| JP2016163571A5 (https=) | ||
| FI3668509T3 (fi) | Menetelmä hoitaa amyotrofista lateraaliskleroosia pridopidiinilla | |
| JP2013520405A5 (https=) | ||
| JP2016147915A5 (https=) | ||
| MA44206A (fr) | Comprimé orodispersible comprenant estetrol | |
| DE60327843D1 (de) | Arzneimittelformulierungen mit verzögerter freisetzung mit einem trägerpeptid | |
| HRP20241221T1 (hr) | POLICIKLIČNI KARBAMOILPIRIDONSKI DERIVATI ZA LIJEČENJE HIV-a | |
| RU2010107843A (ru) | Бупропиона гидробромид и его терапевтические применения | |
| FI3840753T3 (fi) | Migalastaatti käytettäväksi fabryn taudin hoitomenetelmissä potilailla joilla on gla-geenin mutaatio | |
| FI4009942T3 (fi) | Yhdistelmähoitoon tarkoitettu yhdiste | |
| EP4442321A3 (en) | Methods of treating sjögren's syndrome using a bruton's tyrosine kinase inhibitor | |
| JP2020505432A5 (https=) | ||
| FI3846810T3 (fi) | Lasmiditaanin pitkäkestoinen yöaikainen annostus migreenin ennaltaehkäisyyn | |
| PH12020551772A1 (en) | Oxo-substituted compound | |
| WO2018004576A3 (en) | A fast acting orally disintegrating film for administration of local anesthesia | |
| JO3008B1 (ar) | تركيب صيدلي لتخفيف الألم | |
| EP4389218A3 (en) | Composition for treating joint disease and kit containing same | |
| HRP20251043T1 (hr) | Novi oralni farmaceutski pripravak i režim doziranja za terapiju progresivnih fibrozirajućih intersticijskih bolesti pluća | |
| FI4255563T3 (fi) | 5’-o-fenyyliasetyyliuridiini ja terapeuttinen käyttö | |
| RU2007132971A (ru) | Способы и материалы с транс-кломифеном для лечения мужского бесплодия |